LGMD-2D/R3
Showing 26 - 50 of >10,000
Dehydration Trial in Valhalla, Plano (GENPOP Passive dehydration (75% reduction in fluid intake, GENPOP Ad lib fluid intake,
Recruiting
- Dehydration
- GENPOP Passive dehydration (75% reduction in fluid intake
- +3 more
-
Valhalla, New York
- +1 more
Sep 13, 2023
Healthy Participants Trial in Winnipeg (Curcumin, Omega-3 and Vitamin-D (COD))
Recruiting
- Healthy Participants
- Curcumin, Omega-3 and Vitamin-D (COD)
-
Winnipeg, Manitoba, CanadaHealth Sciences Centre
Aug 10, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States
Suspended
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- Cytarabine
- +2 more
-
Los Angeles, California
- +5 more
Dec 10, 2022
Vitamin D Trial in Coquitlam (Vitamin D3)
Recruiting
- Vitamin D
- Vitamin D3
-
Coquitlam, British Columbia, CanadaNatural Factors
Aug 2, 2022
2D and 3D Primary Cell Cultures From Gastric and
Not yet recruiting
- Gastric and Gastroesophageal Junction Cancer
-
Berlin, GermanyDepartment of Anesthesiology and Operative Intensive Care Medici
Sep 13, 2022
Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,
Not yet recruiting
- Insulin Resistance
- +3 more
- Insulin human
- +11 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 6, 2023
Tumoral Kidney Trial in France (3D model pré-operative education)
Not yet recruiting
- Tumoral Kidney
- 3D model pré-operative education
-
Angers, France
- +5 more
Sep 14, 2023
COVID-19 Trial in Campos Dos Goytacazes (AZVUDINE, AZVUDINE )
Completed
- COVID-19
- AZVUDINE
- AZVUDINE placebo
-
Campos Dos Goytacazes, RJ, BrazilSanta Casa de Misericordia de Campos
Aug 10, 2022
Disease Activity in Canadian Adult Moderate-to-Severe Atopic
Recruiting
- Atopic Dermatitis
-
Calgary, Alberta, Canada
- +17 more
Jan 17, 2023
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023
Neat OGTT, OGTT With Added Sucralose, OGTT With Added Lactisole Trial in New Brunswick (TAS1R2/3 agonist or antagoinst admixture
Completed
- Neat OGTT
- +2 more
- TAS1R2/3 agonist or antagoinst admixture to oral glucose tolerance test
-
New Brunswick, New JerseyRutgers, Department of Nutritional Sciences
Jun 2, 2023
Dengue Fever Trial in Dhaka (Arm-2 : 2,00,000 IU Vitamin D3 oral solution , Arm-3: 4,00,000 IU Vitamin D3 oral solution)
Recruiting
- Dengue Fever
- Arm-2 : 2,00,000 IU Vitamin D3 oral solution , Arm-3: 4,00,000 IU Vitamin D3 oral solution
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
Oct 5, 2023
HER-2 Positive Advanced Solid Tumors Trial (D3L-001)
Not yet recruiting
- HER-2 Positive Advanced Solid Tumors
- D3L-001
- (no location specified)
Jul 20, 2023
HF Prevalence and Evolution of HF in DM II Patients at High Risk
Recruiting
- RELATED REGISTRY SEARCH
-
Alexandroupolis, D1843r00313, Greece
- +10 more
Jul 11, 2022
Patients With Limb-Girdle Muscular Dystrophy 2I
Active, not recruiting
- LGMD2I
-
Copenhagen, Denmark
- +2 more
Jan 4, 2022
Aging Trial in Glendale
Withdrawn
- Aging
- (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
- Control
-
Glendale, ArizonaGlencroft Senior Living: Retirement Community in Arizona
Jan 30, 2023
3D Telemedicine: A Clinician Feedback Study
Completed
- Telemedicine
- +2 more
- 3D Telemedicine
- 2D Telemedicine
-
Glasgow, Scotland, United KingdomCanniesburn Regional Plastic Surgery and Burns Unit
May 24, 2022
Myopia Trial in Singapore (Myopia Control Lens-1 (MCL1), Myopia Control Lens-2 (MCL2))
Not yet recruiting
- Myopia
- Myopia Control Lens-1 (MCL1)
- Myopia Control Lens-2 (MCL2)
-
Singapore, SingaporeEssilor R&D Centre Singapore
Nov 27, 2023
Colon Cancer, Resected Stage Trial in Houston (Cetuximab, CB-NK-TGF-βR2-/NR3C1, Fludarabine phosphate)
Recruiting
- Colon Cancer
- Resected Stage
- Cetuximab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 23, 2022
Obesity, Vitamin D3 Deficiency Trial in Rio de Janeiro (Vitamin D3 + K2-MK7, Placebo, Vitamin D3)
Recruiting
- Obesity
- Vitamin D3 Deficiency
- Vitamin D3 + K2-MK7
- +2 more
-
Rio de Janeiro, BrazilRio de Janeiro State University
Jan 10, 2023
Diabetes, Hyperglycemia, Ketosis Trial in Kelowna (D-ß-hydroxybutyric acid with R-1,3-butanediol, Inert )
Not yet recruiting
- Diabetes
- +2 more
- D-β-hydroxybutyric acid with R-1,3-butanediol
- Inert placebo
-
Kelowna, British Columbia, CanadaUniversity of British Columbia
Jul 26, 2022
AML Trial in Hangzhou (NKG2D CAR-NK)
Recruiting
- AML
- NKG2D CAR-NK
-
Hangzhou, Zhejiang, China
- +1 more
Feb 17, 2023
Limb-Girdle Muscular Dystrophy Trial in Worldwide (Deflazacort)
Terminated
- Limb-Girdle Muscular Dystrophy
-
Atlanta, Georgia
- +17 more
May 31, 2022
Diabetes Type 2 With Periodontal Disease Trial in Kirikkale (Vitamin D3K2, Saline Solution)
Completed
- Diabetes Mellitus Type 2 With Periodontal Disease
- Vitamin D3K2
- Saline Solution
-
Kırıkkale, TurkeyKirikkale University
Oct 5, 2023
Depression, Anxiety, Quality of Life Trial in Winnipeg (Focused ACT)
Active, not recruiting
- Depression
- +3 more
- Focused ACT
-
Winnipeg, Manitoba, Canada
- +2 more
Nov 1, 2022